Research programme: live biotherapeutic microbes - Assembly Biosciences
Latest Information Update: 28 Jul 2024
At a glance
- Originator Assembly Biosciences
- Class Antineoplastics; Bacteria
- Mechanism of Action Gastrointestinal microbiome modulators; Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Cancer; Metabolic disorders; Solid tumours
Highest Development Phases
- No development reported Cancer; Metabolic disorders; Solid tumours
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for preclinical development in Solid-tumours in USA (PO)
- 28 Jul 2024 No recent reports of development identified for research development in Cancer in USA (PO)
- 28 Jul 2024 No recent reports of development identified for research development in Metabolic-disorders in USA (PO)